The 20 Best Malakoplakia Doctors Near Me in Rego Park, NY

Christopher Hartman is a Urologist practicing medicine in Rego Park, New York. Dr. Hartman is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Obstructive Uropathy, Enlarged Prostate (BPH), Kidney Stones, Lithotripsy, and Ureteroscopy. Dr. Hartman is board certified in American Board Of Urology.

Jane Cho is an Oncologist and a Urologist practicing medicine in Rego Park, New York. Dr. Cho is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Obstructive Uropathy, Bladder Cancer, Urinary Tract Infection (UTI), Cystectomy, and Ureteroscopy. Dr. Cho is board certified in American Board Of Urology.

Dr. Simon J Hall MD is a board certified urologist with Fellowship training in Urologic Oncology. His clinical interests include the diagnosis and treatment of Prostate, Bladder and Kidney cancers. He is especially interested in Active Surveillance of men with prostate cancer and men and women with incidentally found small renal masses and the creation of continent urinary reconstructions for patients who need to undergo cystectomy for Bladder cancer. Furthermore, Dr. Hall has a keen interest in treating patients with recurrent prostate cancer following definitive therapy. He believes that objective & balanced communication with the patient and family is the key to decision making and individualized care. Over the years Dr. Hall has been named as Best Doctor, both nationally and regionally, by organizations such as Castle Connolly, SuperDoctors and New York Magazine. Dr. Hall s research has focused of new therapies for prostate and bladder cancer; he has participated in numerous clinical trials, some of which generated data resulting in FDA approval of Sipleucel-T (Provenge) and enzulutamide (Xtandi). He oversees a laboratory investigating novel approaches to negating the Androgen Receptor, an important key driver of castration resistant prostate cancer. Decision making and improved methods of clinical care for patients with bladder and prostate cancer are important aspects of his research interests in collaboration with Dr. Michael Diefenbach, a behavioral scientist in the Departments of Urology & Medicine at NS-LIJ. He has authored or co-authored nearly 70 peer reviewed articles in Journals such as Journal of Urology, Urology, British Journal of Urology, Clinical Cancer Research and Science. Dr. Hall received his MD from the College of Physicians & Surgeons of Columbia University. He then completed two years of Surgery training at the Mount Sinai Medical Center followed by a four year residency in Urology at Boston University School of Medicine. This was followed by a 2 year fellowship in Urologic Oncology in the Scott Department of Urology at Baylor College of Medicine. Prior to joining the Smith Institute for Urology, he served on the faculty of Icahn School of Medicine at Mount Sinai for 18 years, holding various positions including Kyung Hyun Kim MD Chair of Urology and the Director of the Deane Prostate Health & Research Center. Dr. Hall is rated as an Advanced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hall is board certified in American Board Of Urology.

Riccardo Ricciardi is a Urologist practicing medicine in Flushing, New York. Dr. Ricciardi is rated as an Advanced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Balanitis, Urinary Tract Infection in Children, Ureteroscopy, and Prostatectomy.

Douglas Scherr is a Urologist practicing medicine in New York, New York. Dr. Scherr is rated as a Distinguished provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy. Dr. Scherr is currently accepting new patients.

Residency Program Director and Director of Quality. Dr. Phillips is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses UPJ Obstruction, Boils, Folliculitis, Carbuncle, and Ureteroscopy. Dr. Phillips is board certified in American Board Of Urology.

Harris M. Nagler, M.D., FACS, has joined the Smith Institute of Urology at Long Island Jewish Medical Center. He previously was Chair of the Sol and Margaret Berger Department of Urology Mount Sinai Beth Israel and President of Beth Israel Medical Center. He was Professor of Urology, Icahn School of Medicine at Mount Sinai.Dr Nagler is an Alpha Omega Alpha graduate of Temple University School of Medicine, which honored him by naming him Alumnus of the Year (2015). He trained at Columbia Presbyterian Medical Center where he was on the faculty.Dr. Nagler is the recipient of many national and regional honors. He has been recognized numerous times in New York Magazine s Best Doctors listing and Best Doctors in the United States.He has received recognition as a clinician/researcher. Columbia University honored him with Drs. Harold and Goldman Lampert Award for Excellence in Clinical Research. He received the ACMI Urology Prize of the American Fertility Society, First Prize for Clinical Research in the AUA Prize Essay Contest, the AFS Urology Prize, the John K. Lattimer Award of the Kidney and Urology Foundation of America,the Russell Lavengood Award for Distinguished Service from the New York Section of the AUA.Dr Nagler is a member or many prestigious organizations including the Alpha Omega Alpha medical Honor Society. In addition to membership in these societies he was the President of the Society for the Study of Male Reproduction of the American Urological Association and President of the Society of Reproductive Surgeons of the American Society of Reproductive Medicine and President of the New York Section of the American Urological Association.He is currently Secretary/ Treasurer of the SMRU of the American Society of Reproductive Medicine. He is and has had editorial responsibilities for many urologic journals.He has published extensively in peer reviewed journals on many Urological topics and has co-edited four books focusing on the treatment of male infertility.He has been recognized by the American Urological Association with the Distinguished Service Award He received the Culman Award of the Mount Sinai Health care system for excellence in patient communication in 2016. Dr Nagler s practice focuses on male infertility and erectile dysfunction. Dr. Nagler is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Sertoli Cell-Only Syndrome, Varicocele, Spermatogenesis Arrest, and Premature Ejaculation. Dr. Nagler is board certified in American Board Of Urology.

Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco. Dr. Richstone is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Richstone is board certified in American Board Of Urology.

Farzeen Firoozi, MD is the System Director of Female Pelvic Medicine and Reconstructive Surgery at the Department of Urology at Lenox Hill Hospital. Dr. Firoozi is an expert in laparoscopic and robotic surgery for pelvic floor reconstruction. His clinical interests include urinary incontinence, pelvic organ prolapse, complex reconstruction of the lower urinary tract, and management of complications of vaginal and lower urinary tract surgery. After completing his urology residency at Albany Medical Center, Dr. Firoozi completed his fellowship at the prestigious Cleveland Clinic, with specialization in male and female voiding dysfunction, pelvic organ prolapse, incontinence, overactive bladder and neuro-urology -- one of few fellowships formally recognized by both the American Board of Urology and American Board of Obstetrics and Gynecology.Dr. Firoozi has pioneered, innovated and published new methods for the treatment of combined pelvic organ prolapse. In addition to performing the first ever reported transvesical Laparoendoscopic Single Site Surgery (LESS) for the management of vaginal mesh complications, Dr. Firoozi gained extensive experience with robotic and laparoscopic reconstructive surgery while at the Cleveland Clinic. Dr. Firoozi has presented at numerous national and international meetings, and won multiple awards for his work. He is an active member of the American Urological Association, International Urogynecology Association, and the Society for Urodynamics and Female Urology.He has been published in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, Urologic Clinics of North America, European Urology, and the International Urogynecology Journal. Dr. Firoozi has also written many book chapters for some of the leading editors in his field.Dr. Firoozi has recently published two textbooks, Female Pelvic Surgery and Interpretation of Basic and Advanced Urodynamics.Dr. Firoozi has been named a Rising Star Superdoctor in the New York Times Magazine in 2013 and 2014, and named Superdoctor in 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022 and 2023.Dr. Firoozi is one of very few physicians with accredited, formal fellowship training in the field of Female Pelvic Medicine and Reconstructive Surgery in New York Metro Area. He was also part of the first group of surgeons to become certified in the subspecialty field of Female Pelvic Medicine and Reconstructive Surgery.In addition to practicing and advancing his specialty through innovation and education, Dr. Firoozi places compassion for his patients and their needs at the top of his priority list. Dr. Firoozi is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Urinary Incontinence, Stress Urinary Incontinence, Neurogenic Bladder, Sacral Nerve Stimulation, and Ureteroscopy. Dr. Firoozi is board certified in American Board Of Urology and American Board Of Urology/Urogynecology And Reconstructive Pelvic Surgery.

Gary Weiss is a Urologist practicing medicine in Great Neck, New York. Dr. Weiss is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Ureteroscopy, and Prostatectomy. Dr. Weiss is board certified in American Board Of Urology.

Alexander I. Sankin, MD, is Professor, Urology at Montefiore Einstein. His clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer. Dr. Sankin is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Ureteroscopy.

Erin Ohmann, MD, is an attending physician and Assistant Professor of Urology at Montefiore Einstein. Her clinical focus is general urology with a special interest in endourology and male and female voiding dysfunction. She specializes in treating conditions such as benign prostatic hypertrophy, urinary retention, urinary incontinence, overactive bladder, kidney stones, bladder stones, bladder cancer and prostate cancer. Dr. Ohmann is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Neurogenic Bladder, Kidney Stones, Enlarged Prostate (BPH), Ureteroscopy, and Lithotripsy.

Joph Steckel is a Urologist practicing medicine in Lake Success, New York. Dr. Steckel is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Steckel is board certified in American Board Of Urology.

David M. Hoenig, MD, is a specialist in kidney stone treatment and minimally invasive surgery, including laparoscopic surgery. His specific clinical interests include all phases of kidney stone disease, from surgical treatment, to medical management, and to prevention. Dr. Hoenig completed medical school at the University of Rochester (Rochester, NY), and residency in Urology at Brown University (Providence, RI). He went on to one of the premier Laparoscopy and Endourology Fellowships in the country, under Dr. Ralph V. Clayman, one of the pioneers of minimally invasive urologic surgery, at Washington University (St. Louis, MO).After Fellowship training, Dr. Hoenig became a Clinical Instructor at the Medical College of Pennsylvania/Hahnemann under the auspices of Allegheny University, and was then recruited to Montefiore Medical Center/Albert Einstein College of Medicine to become the Director of Laparoscopy and Endourology and promoted to Assistant Professor. While at Montefiore, Dr. Hoenig assumed many administrative roles, as co-founder and co-Director of the Robotic, Laparoscopy, and Endourology Fellowship, Residency Program Director, and Practice Manager. After more than 14 years at Montefiore/Albert Einstein, he was recruited to North Shore- Long Island Jewish Hospital in 2013 with a promotion to Professor, and a shift of administrative roles to Chief of Urology Service at LIJ Hospital Campus. Dr. Hoenig's research interests are in all phases of minimally invasive urologic surgery, with particular attention to kidney stone disease, and both ablative and reconstructive minimally invasive renal surgery. His most recent publications explore the association of obesity with urological diseases, with new associations discovered between types of obesity and certain kidney stones. This research focus is a priority, given the national trend of increasing obesity, and will lead to exciting basic science exploration of these conditions.As a clinician, Dr. Hoenig's priority is treating patients with respect and empathy. He believes strongly in educating patients about their conditions, so as to equip them with the necessary information to make them a partner in their health care. Dr. Hoenig is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Medullary Sponge Kidney, Perirenal Abscess, Ureteroscopy, and Endoscopy. Dr. Hoenig is board certified in American Board Of Urology.

David Chan is a Urologist practicing medicine in Lake Success, New York. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Obstructive Uropathy, Boils, Ureteroscopy, and Prostatectomy. Dr. Chan is board certified in American Board Of Urology.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kavoussi is board certified in American Board Of Urology.

Justin S. Han, MD is an Associate Professor of Urology and Residency Program Director for the Hofstra-Northwell Zucker School of Medicine Urology Residency Program. Dr. Han serves as the Director of Male Reconstructive Urology and Prosthetics at the Smith Institute for Urology and is a specialist in urologic reconstruction and male incontinence. Dr. Han received his medical degree from Northwestern University Feinberg School of Medicine and completed his urology residency training at New York University Medical Center. Dr. Han joined the Smith Institute for Urology at Northwell Health following a fellowship in Genitourinary Reconstruction and Prosthetics at Northwestern Memorial Hospital.Dr. Han's clinical and academic interests include urethral strictures, urologic prosthetics, erectile dysfunction, and male voiding dysfunction. He has a strong focus on resident medical education and mentorship as well as healthcare quality and improvement. His fellowship training focused on a variety of reconstructive surgeries, including urethroplasty, artificial urinary sphincter, male slings, Peyronie's reconstruction, and minimally invasive surgery. Beyond technical skills, Dr. Han is dedicated to improving his patients' quality of life and providing compassionate, patient-centered care. His complete focus is on helping patients regain control of their lives and restoring their quality of life. Dr. Han is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Urethral Stricture, Obstructive Uropathy, Urinary Incontinence, Enlarged Prostate (BPH), and Ureteroscopy. Dr. Han is board certified in American Board Of Urology.

Michael J. Schwartz, MD, is Chief of Urology at Long Island Jewish Medical Center and Director of Urology Services for Northwell Health's Central Region. Dr. Schwartz specializes in minimally invasive procedures to treat prostate cancer. He has vast experience in robotic-assisted radical prostatectomy, evolving surgical techniques over time to minimize treatment-related side effects. For qualifying prostate cancer patients, Dr. Schwartz also offers focal ablation therapies, using sophisticated image guidance and focal tissue ablation to eradicate prostate cancer with few side effects. He has additional expertise in urologic oncology and surgery to treat kidney, bladder, adrenal and testicular cancers. Becoming a doctor always felt natural to me, Dr. Schwartz says. I was always interested in helping others, and urology is a wonderful blend of both medical and surgical care, allowing for the development of long-term relationships with my patients. Dr. Schwartz earned his medical degree from Warren Alpert Medical School of Brown University and pursued his residency training in urology at New York-Presbyterian Hospital, Cornell. He received his fellowship training in advanced laparoscopic and endoscopic surgery at North Shore University Hospital and Long Island Jewish Medical Center. Dr. Schwartz values a team-based approach to care, working with radiologists, pathologists and medical oncologists to create individualized, evidence-based treatment plans. He also carefully listens to patients to meet their unique goals and preferences. In addition to treating prostate cancer, Dr. Schwartz is a pioneer in prostate cancer diagnosis. He was an early adopter of transperineal biopsy-which eliminates the infection risk associated with the prior transrectal method-and helped the Smith Institute of Urology transition to using that approach for all patients requiring prostate biopsy across Northwell Health. His research focuses on both diagnostics and treatment of prostate cancer, and he is involved with several clinical trials for focal therapy. He is a member of the American Urological Association and Society of Urologic Oncology. He is Associate Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. For Dr. Schwartz, one of the best parts of his job is getting to know his patients. I have the privilege of seeing their humanity, learning about their lives and discovering what's important to them, he says. Their experiences inspire me every day. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Reconstructive Urology Surgery, and Nephrectomy. Dr. Schwartz is board certified in American Board Of Urology.

As Senior Vice President of the Urology Service Line, Chair of theSmith Institute for Urology, and Chair of Urology at the Zucker Schoolof Medicine at Hofstra/Northwell, Samir Taneja, MD will establish hisclinical practice at Lenox Hill Hospital and Long Island Jewish MedicalCenter focused on the surgical management of prostate cancerand renal tumors. He is an expert in urologic oncology, renowned fortransforming the field of prostate cancer diagnosis and treatmentby improving methods of prostate imaging, cancer detection, anddisease localization. Having performed thousands of robotic, ablative,laparoscopic and open surgical procedures, his specific clinical focushas been in improving prostate cancer patient outcomes throughpioneering techniques for focal ablative therapy, refining surgicaltechniques for robotic prostatectomy and partial nephrectomy,devising accelerated recovery pathways for robotic prostatectomy/partial nephrectomy, and providing muti-modal surgical approachesfor patients with high risk and recurrent prostate cancer. As leader ofthe department, he will strive to ensure individualized care of urologicdisease through state-of-the-art surgical approaches and multi-disciplinary care.Prior to joining Northwell, Dr Taneja was a faculty member of NYUGrossman School of Medicine for 29-years as a tenured professorof urology, radiology, and biomedical engineering. Most recently heserved as Director of the Division of Urologic Oncology and ViceChair in the Department of Urology at NYU Langone Health, as well asGenitourinary Program Leader in the Perlmutter Cancer Center.Dr. Taneja has conducted extensive clinical research on the use ofimaging in prostate cancer and is considered a pioneer in the use ofMRI to diagnose and localize prostate cancer and the emerging field ofprostate cancer focal therapy. He has authored more than 250 articles,30 book chapters, and six textbooks and monographs on urologiccancer and surgery. He is the editor of Taneja's Complications ofUrologic Surgery: Prevention and Diagnosis, one of the most widely readtextbooks in American Urology. Dr. Taneja is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Taneja is board certified in American Board Of Urology.

Zeph Okeke, MD is a board certified urologic surgeon specializing in endourology, minimally invasive surgery and laparoscopy. He is known for developing and being the principal investigator of the novel S.T.O.N.E. classification system for kidney stones.His expertise is in using minimally invasive techniques for the management of complex kidney and ureteral stone disease, and urothelial cancers (transitional cell carcinoma) of the kidney and ureter. He also has special interest and expertise in Holmium and Thulium laser enucleation (HOLEP and ThuLEP) for enlarged prostates (BPH).In addition to treating patients and conducting research, Dr. Okeke serves as co-director of the Smith Institute for Urology endourology and laparoscopy fellowship training programs. He lectures at the American Urological Association s annual meetings and is frequently invited to speak before the World Congress of Endourology. A mentor and teacher, Dr. Okeke also serves as a surgeon and lecturer for live surgical demonstration courses at various international meetings.Dr. Okeke earned his medical degree from Cornell University Medical College in New York City. He completed his Urology residency and served as Chief Resident in the Department of Urology at the New York Presbyterian Hospital-Columbia University College of Physicians & Surgeons.Dr. Okeke's research interest includes surgical outcomes of kidney stone patients, grading and characterizing complex kidney stones to guide surgery and counseling with respect to outcomes. He has published in leading journals and textbooks including the Smith's Textbook of Endourology, Journal of Urology, Urology and Cancer.He is the recipient of the Teacher of the Year Award at the North Shore LIJ Health System. Dr. Okeke also received the prestigious Arnold P. Gold Foundation Teaching Award for Humanism and Excellence in Teaching. Columbia University College of Physicians & Surgeons awarded its first Lifetime Achievement Award to Dr. Okeke for medical student teaching during his residency. Dr. Okeke is rated as an Experienced provider by MediFind in the treatment of Malakoplakia. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Bladder Stones, Horseshoe Kidney, Ureteroscopy, and Endoscopy.